Understanding the Chronic Disease Patient Journey in Emerging Markets
With growing urban populations and increasing purchasing power, emerging markets remain an attractive prospect for growth. A high proportion of the urban emerging market population already suffer from chronic diseases and prevalence is set to further increase as lifestyles become closer to those in the West.
The chronic disease patient is a critical stakeholder in emerging markets because they often have to pay for their healthcare out of pocket. Moreover these markets often don’t have formal primary care systems, so the patient is the only constant in the journey. Understanding their journey is critical in order to fully exploit these potential new markets.
The Art of Storytelling in Pharma Market Research
Effectively communicating research insights is a major focus for today’s market researcher, particularly in global healthcare. It’s not enough now just to present the research evidence. We must tell the story, using a clear narrative to engage a broad and often disparate group of stakeholders. In this short webinar we will explore the principles of storytelling in pharma market research and show you how you to find and share your story.
Understanding the Patient Journey in China 2015
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.
The Chinese healthcare market is experiencing a period of great change. Utilising local knowledge and detailed case studies, this webinar (the latest in our series on China and emerging markets) will examine the likely impact on the patient journey and consider the possible implications for market researchers.
Uncovering Latin America
Latin America is a pharma market on the move. Economic growth, urbanisation and a booming middle class have all helped foster athriving pharma region which is currently witnessing 12% annual growth.
However Latin America is a highly complex and heterogeneous region where the opportunities - and challenges - for pharma often differ significantly, not just by country but also within. Should we therefore be considering Latin America as not one region, but multiple regions?
In this webinar our Emerging Market experts will address the major economic, demographic andhealthcare trends across the region, as well as provide you with the key considerations for implementing effective regional market research programmes.
How to conduct effective market research in emerging markets
Pharmaceutical market research is still evolving in many emerging markets and so finding the insights you require can be a challenge.
In this webinar, using examples from a wide range of emerging markets, we will explain the important cultural, methodological and quality considerations and provide you with the core critical success factors to guaranteeing effective primary research in emerging markets.